133 related articles for article (PubMed ID: 3430242)
1. Effects of gliadin peptides B1-B4 in celiac disease. I. Organ culture studies.
Stallmach A; Belitz HD; Gellermann B; Schäfer H; Wieser H; Stern M
J Pediatr Gastroenterol Nutr; 1987; 6(3):335-40. PubMed ID: 3430242
[TBL] [Abstract][Full Text] [Related]
2. Intestinal mucosa of celiacs in remission is unable to abolish toxicity of gliadin peptides on in vitro developing fetal rat intestine and cultured atrophic celiac mucosa.
Cornell HJ; Auricchio RS; De Ritis G; De Vincenzi M; Maiuri L; Raia V; Silano V
Pediatr Res; 1988 Aug; 24(2):233-7. PubMed ID: 3186334
[TBL] [Abstract][Full Text] [Related]
3. In vitro (organ culture) studies of the toxicity of specific A-gliadin peptides in celiac disease.
de Ritis G; Auricchio S; Jones HW; Lew EJ; Bernardin JE; Kasarda DD
Gastroenterology; 1988 Jan; 94(1):41-9. PubMed ID: 3335296
[TBL] [Abstract][Full Text] [Related]
4. Characterizing one of the DQ2 candidate epitopes in coeliac disease: A-gliadin 51-70 toxicity assessed using an organ culture system.
Martucci S; Fraser JS; Biagi F; Corazza GR; Ciclitira PJ; Ellis HJ
Eur J Gastroenterol Hepatol; 2003 Dec; 15(12):1293-8. PubMed ID: 14624152
[TBL] [Abstract][Full Text] [Related]
5. Targeting of gliadin peptides, CD8, alpha/beta-TCR, and gamma/delta-TCR to Golgi complexes and vacuoles within celiac disease enterocytes.
Zimmer KP; Naim H; Weber P; Ellis HJ; Ciclitira PJ
FASEB J; 1998 Oct; 12(13):1349-57. PubMed ID: 9761778
[TBL] [Abstract][Full Text] [Related]
6. In vitro activities of A-gliadin-related synthetic peptides: damaging effect on the atrophic coeliac mucosa and activation of mucosal immune response in the treated coeliac mucosa.
Maiuri L; Troncone R; Mayer M; Coletta S; Picarelli A; De Vincenzi M; Pavone V; Auricchio S
Scand J Gastroenterol; 1996 Mar; 31(3):247-53. PubMed ID: 8833354
[TBL] [Abstract][Full Text] [Related]
7. An in vitro model of gluten-sensitive enteropathy. Effect of gliadin on intestinal epithelial cells of patients with gluten-sensitive enteropathy in organ culture.
Falchuk ZM; Gebhard RL; Sessoms C; Strober W
J Clin Invest; 1974 Feb; 53(2):487-500. PubMed ID: 11344562
[TBL] [Abstract][Full Text] [Related]
8. Enhanced peptide-binding capacities of small intestinal brush border membranes in celiac disease.
Bolte G; Seilmeier W; Wieser H; Holm K; Beuermann K; Newport B; Stern M
Pediatr Res; 1999 Dec; 46(6):666-70. PubMed ID: 10590021
[TBL] [Abstract][Full Text] [Related]
9. In vitro activation of adenylate cyclase of atrophic celiac intestinal mucosa by wheat gliadin-derived peptides.
Beguinot L; Auricchio S; Bernardin JE; de Ritis G; De Vincenzi M; Kasarda DD; Macchia V; Silano V
Pediatr Res; 1986 Jan; 20(1):42-4. PubMed ID: 3945514
[TBL] [Abstract][Full Text] [Related]
10. In vitro hydrolysis of gliadin and casein peptides: secondary defect in coeliac disease shown by organ culture.
Walz F; Wieser H; Stern M
Scand J Gastroenterol; 1996 Mar; 31(3):240-6. PubMed ID: 8833353
[TBL] [Abstract][Full Text] [Related]
11. Gliadin activates HLA class I-restricted CD8+ T cells in celiac disease intestinal mucosa and induces the enterocyte apoptosis.
Mazzarella G; Stefanile R; Camarca A; Giliberti P; Cosentini E; Marano C; Iaquinto G; Giardullo N; Auricchio S; Sette A; Troncone R; Gianfrani C
Gastroenterology; 2008 Apr; 134(4):1017-27. PubMed ID: 18395083
[TBL] [Abstract][Full Text] [Related]
12. Breakdown of gliadin peptides by intestinal brush borders from coeliac patients.
Bruce G; Woodley JF; Swan CH
Gut; 1984 Sep; 25(9):919-24. PubMed ID: 6381246
[TBL] [Abstract][Full Text] [Related]
13. [Effect of gliadin on cholesterol synthesis of the enterocytes in celiac disease in children].
Kuberger MB; Izachik NA; Izachik IuA
Pediatriia; 1988; (11):15-9. PubMed ID: 3226797
[No Abstract] [Full Text] [Related]
14. Are all gliadins toxic in coeliac disease? An in vitro study of alpha, beta, gamma, and w gliadins.
Howdle PD; Ciclitira PJ; Simpson FG; Losowsky MS
Scand J Gastroenterol; 1984 Jan; 19(1):41-7. PubMed ID: 6710076
[TBL] [Abstract][Full Text] [Related]
15. Alterations of the intestinal transport and processing of gliadin peptides in celiac disease.
Matysiak-Budnik T; Candalh C; Dugave C; Namane A; Cellier C; Cerf-Bensussan N; Heyman M
Gastroenterology; 2003 Sep; 125(3):696-707. PubMed ID: 12949716
[TBL] [Abstract][Full Text] [Related]
16. In vitro toxicity of gluten peptides in coeliac disease assessed by organ culture.
Shidrawi RG; Day P; Przemioslo R; Ellis HJ; Nelufer JM; Ciclitira PJ
Scand J Gastroenterol; 1995 Aug; 30(8):758-63. PubMed ID: 7481543
[TBL] [Abstract][Full Text] [Related]
17. Amino acid composition of gliadin fractions which may be toxic to individuals with coeliac disease.
Cornell HJ; Maxwell RJ
Clin Chim Acta; 1982 Aug; 123(3):311-9. PubMed ID: 6811164
[TBL] [Abstract][Full Text] [Related]
18. In vitro mucosal digestion of synthetic gliadin-derived peptides in celiac disease.
Cornell HJ; Rivett DE
J Protein Chem; 1995 Jul; 14(5):335-9. PubMed ID: 8590601
[TBL] [Abstract][Full Text] [Related]
19. In vitro pathogenetic studies of coeliac disease. Effects of protein digests on coeliac intestinal biopsy specimens maintained in culture for 48 hours.
Jos J; Lenoir G; Ritis G D; Rey J
Scand J Gastroenterol; 1975; 10(2):121-8. PubMed ID: 1091964
[TBL] [Abstract][Full Text] [Related]
20. Handling of gliadin peptides B1-B4 and of cow's milk proteins by rat jejunum gut sacs.
Melter M; Belitz HD; Gellermann B; Wieser H; Stern M
J Pediatr Gastroenterol Nutr; 1988; 7(2):196-202. PubMed ID: 3351703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
